Effect of Some Immunomodulators Use Together with PPR Vaccine on Immune system in Morkaraman Sheep
Abstract
In this study, it was aimed to investigate the effects of vitamin C (Vit-C), vitamin D (Vit-D), levamisole (LMS), inactivated parapoxvirus ovis (iPPVO) and corynebacterium cutis lysate (CCL) on the immune system in Morkaraman sheep on which the peste des petitis ruminant (PPR) vaccine was administered. In the Group B (Vit-D + PPR vaccine), in terms of IgG, when compared 0th, 14th, 21st and 28th, the values of the day 7th were determined to be significantly higher (P<0.01). In comparison to overall evaluation based on groups of IgG assay, the Group C (LMS + PPR vaccine) value was determined to be significantly higher than the Group F (PPR vaccine), Group A (Vit-C + PPR vaccine), Group B and Group D (iPPVO + PPR vaccine) values (P<0.01). In terms of IgM, when days among groups are compared, the highest value was determined on the 7th day in the Group A and this value was determined to be significant according to the 7th day Group F, Group E (CCL + PPR vaccine) and Group D values (P<0.01). The application of LMS at the stated dose had positive effects on the immune system due to changes in both IgM and IgG values, and Vit-C application at the stated dose had a partially positive effect only due to changes in IgM value; the administration of Vit-D, iPPVO and CCL at the stated doses did not have any positive effect on the immune system.
Article Details
- Zitationsvorschlag
-
Aydın, Ö, & Aktaş, M. (2023). Effect of Some Immunomodulators Use Together with PPR Vaccine on Immune system in Morkaraman Sheep . Journal of the Hellenic Veterinary Medical Society, 74(2), 5573–5582. https://doi.org/10.12681/jhvms.28070 (Original work published 4. Juli 2023)
- Ausgabe
- Bd. 74 Nr. 2 (2023)
- Rubrik
- Research Articles
Dieses Werk steht unter der Lizenz Creative Commons Namensnennung - Nicht-kommerziell 4.0 International.
Authors who publish with this journal agree to the following terms:
· Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution Non-Commercial License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
· Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g. post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
· Authors are permitted and encouraged to post their work online (preferably in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.